| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.24 | 2e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.095 | 0.03 |